Dermal Granuloma Annulare After SARS-CoV-2 Vaccination: A Rare Complication
Granuloma annulare (GA) is an inflammatory granulomatous skin disease of unknown etiology that is self-limiting in nature. However, it is hypothesized that trauma, medications, malignancy, viral infections, different vaccines, and hypersensitivity reactions can trigger the formation of GA. Only thre...
Gespeichert in:
| Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2024-01, Vol.16 (1), p.e52174 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | e52174 |
| container_title | Curēus (Palo Alto, CA) |
| container_volume | 16 |
| creator | Tahir, Muhammad Bodies, Belin F Shalin, Sara Phung, Thuy Myers, Thomas C Israel, Robert Piris, Adriano Knowles, Kurt |
| description | Granuloma annulare (GA) is an inflammatory granulomatous skin disease of unknown etiology that is self-limiting in nature. However, it is hypothesized that trauma, medications, malignancy, viral infections, different vaccines, and hypersensitivity reactions can trigger the formation of GA. Only three cases of post-SARS-CoV-2 vaccination-related GA have been reported so far. Here, we report the fourth documented case of post-SARS-CoV-2 vaccination-related generalized GA. |
| doi_str_mv | 10.7759/cureus.52174 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10859147</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2933372882</sourcerecordid><originalsourceid>FETCH-LOGICAL-c267t-9e52b2d8fb8f26e873935e2e13084cd8ae4b458cef3b8a9c9f2c6e18f41fb9fd3</originalsourceid><addsrcrecordid>eNpVkN1LwzAUxYMobsy9-SwFX-3MV5vEFylVpzgQNt1rSNNEO9pmpq3gf2-36ZhP93Dvj3MPB4BzBCeMReJad950zSTCiNEjMMQo5iFHnB4f6AEYN80KQoggw5DBUzAgnFAaUToEz3fGV6oMpl7VXekqFSR1L5Q3QWJb44NFMl-EqVuGOFgqrYtatYWrb4IkmG-g1FXrstDb5Rk4sapszPh3jsDbw_1r-hjOXqZPaTILNY5ZGwoT4Qzn3Gbc4thwRgSJDDaIQE51zpWhGY24NpZkXAktLNaxQdxSZDNhczICtzvfdZdVJtembr0q5doXlfLf0qlC_r_UxYd8d18SQR4JRFnvcPnr4N1nZ5pWrlzn6z60xIIQwjDnuKeudpT2rmm8sfsXCMpN_XJXv9zW3-MXh7H28F_Z5AccWoGc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2933372882</pqid></control><display><type>article</type><title>Dermal Granuloma Annulare After SARS-CoV-2 Vaccination: A Rare Complication</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Tahir, Muhammad ; Bodies, Belin F ; Shalin, Sara ; Phung, Thuy ; Myers, Thomas C ; Israel, Robert ; Piris, Adriano ; Knowles, Kurt</creator><creatorcontrib>Tahir, Muhammad ; Bodies, Belin F ; Shalin, Sara ; Phung, Thuy ; Myers, Thomas C ; Israel, Robert ; Piris, Adriano ; Knowles, Kurt</creatorcontrib><description>Granuloma annulare (GA) is an inflammatory granulomatous skin disease of unknown etiology that is self-limiting in nature. However, it is hypothesized that trauma, medications, malignancy, viral infections, different vaccines, and hypersensitivity reactions can trigger the formation of GA. Only three cases of post-SARS-CoV-2 vaccination-related GA have been reported so far. Here, we report the fourth documented case of post-SARS-CoV-2 vaccination-related generalized GA.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.52174</identifier><identifier>PMID: 38344544</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Abdomen ; Acids ; Biopsy ; Collagen ; COVID-19 vaccines ; Cytokine storm ; Dermatology ; Drug dosages ; Females ; Granulomas ; Hospitals ; Immune system ; Internal Medicine ; Pathogenesis ; Pathology ; Patients ; Severe acute respiratory syndrome coronavirus 2 ; Skin ; Steroids ; Tumor necrosis factor-TNF ; White people</subject><ispartof>Curēus (Palo Alto, CA), 2024-01, Vol.16 (1), p.e52174</ispartof><rights>Copyright © 2024, Tahir et al.</rights><rights>Copyright © 2024, Tahir et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2024, Tahir et al. 2024 Tahir et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c267t-9e52b2d8fb8f26e873935e2e13084cd8ae4b458cef3b8a9c9f2c6e18f41fb9fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10859147/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10859147/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38344544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tahir, Muhammad</creatorcontrib><creatorcontrib>Bodies, Belin F</creatorcontrib><creatorcontrib>Shalin, Sara</creatorcontrib><creatorcontrib>Phung, Thuy</creatorcontrib><creatorcontrib>Myers, Thomas C</creatorcontrib><creatorcontrib>Israel, Robert</creatorcontrib><creatorcontrib>Piris, Adriano</creatorcontrib><creatorcontrib>Knowles, Kurt</creatorcontrib><title>Dermal Granuloma Annulare After SARS-CoV-2 Vaccination: A Rare Complication</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Granuloma annulare (GA) is an inflammatory granulomatous skin disease of unknown etiology that is self-limiting in nature. However, it is hypothesized that trauma, medications, malignancy, viral infections, different vaccines, and hypersensitivity reactions can trigger the formation of GA. Only three cases of post-SARS-CoV-2 vaccination-related GA have been reported so far. Here, we report the fourth documented case of post-SARS-CoV-2 vaccination-related generalized GA.</description><subject>Abdomen</subject><subject>Acids</subject><subject>Biopsy</subject><subject>Collagen</subject><subject>COVID-19 vaccines</subject><subject>Cytokine storm</subject><subject>Dermatology</subject><subject>Drug dosages</subject><subject>Females</subject><subject>Granulomas</subject><subject>Hospitals</subject><subject>Immune system</subject><subject>Internal Medicine</subject><subject>Pathogenesis</subject><subject>Pathology</subject><subject>Patients</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Skin</subject><subject>Steroids</subject><subject>Tumor necrosis factor-TNF</subject><subject>White people</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVkN1LwzAUxYMobsy9-SwFX-3MV5vEFylVpzgQNt1rSNNEO9pmpq3gf2-36ZhP93Dvj3MPB4BzBCeMReJad950zSTCiNEjMMQo5iFHnB4f6AEYN80KQoggw5DBUzAgnFAaUToEz3fGV6oMpl7VXekqFSR1L5Q3QWJb44NFMl-EqVuGOFgqrYtatYWrb4IkmG-g1FXrstDb5Rk4sapszPh3jsDbw_1r-hjOXqZPaTILNY5ZGwoT4Qzn3Gbc4thwRgSJDDaIQE51zpWhGY24NpZkXAktLNaxQdxSZDNhczICtzvfdZdVJtembr0q5doXlfLf0qlC_r_UxYd8d18SQR4JRFnvcPnr4N1nZ5pWrlzn6z60xIIQwjDnuKeudpT2rmm8sfsXCMpN_XJXv9zW3-MXh7H28F_Z5AccWoGc</recordid><startdate>20240112</startdate><enddate>20240112</enddate><creator>Tahir, Muhammad</creator><creator>Bodies, Belin F</creator><creator>Shalin, Sara</creator><creator>Phung, Thuy</creator><creator>Myers, Thomas C</creator><creator>Israel, Robert</creator><creator>Piris, Adriano</creator><creator>Knowles, Kurt</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20240112</creationdate><title>Dermal Granuloma Annulare After SARS-CoV-2 Vaccination: A Rare Complication</title><author>Tahir, Muhammad ; Bodies, Belin F ; Shalin, Sara ; Phung, Thuy ; Myers, Thomas C ; Israel, Robert ; Piris, Adriano ; Knowles, Kurt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c267t-9e52b2d8fb8f26e873935e2e13084cd8ae4b458cef3b8a9c9f2c6e18f41fb9fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abdomen</topic><topic>Acids</topic><topic>Biopsy</topic><topic>Collagen</topic><topic>COVID-19 vaccines</topic><topic>Cytokine storm</topic><topic>Dermatology</topic><topic>Drug dosages</topic><topic>Females</topic><topic>Granulomas</topic><topic>Hospitals</topic><topic>Immune system</topic><topic>Internal Medicine</topic><topic>Pathogenesis</topic><topic>Pathology</topic><topic>Patients</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Skin</topic><topic>Steroids</topic><topic>Tumor necrosis factor-TNF</topic><topic>White people</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tahir, Muhammad</creatorcontrib><creatorcontrib>Bodies, Belin F</creatorcontrib><creatorcontrib>Shalin, Sara</creatorcontrib><creatorcontrib>Phung, Thuy</creatorcontrib><creatorcontrib>Myers, Thomas C</creatorcontrib><creatorcontrib>Israel, Robert</creatorcontrib><creatorcontrib>Piris, Adriano</creatorcontrib><creatorcontrib>Knowles, Kurt</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tahir, Muhammad</au><au>Bodies, Belin F</au><au>Shalin, Sara</au><au>Phung, Thuy</au><au>Myers, Thomas C</au><au>Israel, Robert</au><au>Piris, Adriano</au><au>Knowles, Kurt</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dermal Granuloma Annulare After SARS-CoV-2 Vaccination: A Rare Complication</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-01-12</date><risdate>2024</risdate><volume>16</volume><issue>1</issue><spage>e52174</spage><pages>e52174-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Granuloma annulare (GA) is an inflammatory granulomatous skin disease of unknown etiology that is self-limiting in nature. However, it is hypothesized that trauma, medications, malignancy, viral infections, different vaccines, and hypersensitivity reactions can trigger the formation of GA. Only three cases of post-SARS-CoV-2 vaccination-related GA have been reported so far. Here, we report the fourth documented case of post-SARS-CoV-2 vaccination-related generalized GA.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>38344544</pmid><doi>10.7759/cureus.52174</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-8184 |
| ispartof | Curēus (Palo Alto, CA), 2024-01, Vol.16 (1), p.e52174 |
| issn | 2168-8184 2168-8184 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10859147 |
| source | PubMed Central Open Access; PubMed Central |
| subjects | Abdomen Acids Biopsy Collagen COVID-19 vaccines Cytokine storm Dermatology Drug dosages Females Granulomas Hospitals Immune system Internal Medicine Pathogenesis Pathology Patients Severe acute respiratory syndrome coronavirus 2 Skin Steroids Tumor necrosis factor-TNF White people |
| title | Dermal Granuloma Annulare After SARS-CoV-2 Vaccination: A Rare Complication |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T05%3A28%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dermal%20Granuloma%20Annulare%20After%20SARS-CoV-2%20Vaccination:%20A%20Rare%20Complication&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Tahir,%20Muhammad&rft.date=2024-01-12&rft.volume=16&rft.issue=1&rft.spage=e52174&rft.pages=e52174-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.52174&rft_dat=%3Cproquest_pubme%3E2933372882%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2933372882&rft_id=info:pmid/38344544&rfr_iscdi=true |